{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:20:39Z","timestamp":1792686039093,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s15010-023-02132-6","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T18:01:35Z","timestamp":1700762495000},"page":"891-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4243-9663","authenticated-orcid":false,"given":"Jianglin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3045-1710","authenticated-orcid":false,"given":"Zhenzhen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"issue":"Suppl 1","key":"2132_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0168-8278(97)82330-6","volume":"26","author":"VJ Desmet","year":"1997","unstructured":"Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol. 1997;26(Suppl 1):31\u20135.","journal-title":"J Hepatol"},{"key":"2132_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cld.2007.11.007","volume":"12","author":"NS Reau","year":"2008","unstructured":"Reau NS, Jensen DM. Vanishing bile duct syndrome. Clin Liver Dis. 2008;12:203\u201317.","journal-title":"Clin Liver Dis"},{"key":"2132_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2021.12.043","volume":"76","author":"J Ahmad","year":"2022","unstructured":"Ahmad J, Barnhart HX, Bonacini M, et al. Value of liver biopsy in the diagnosis of drug-induced liver injury. J Hepatol. 2022;76:1070\u20138.","journal-title":"J Hepatol"},{"key":"2132_CR4","first-page":"1017","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver Biopsy Hepatol. 2009;49:1017\u201344.","journal-title":"Liver Biopsy Hepatol"},{"key":"2132_CR5","first-page":"1232","volume":"15","author":"AP Geubel","year":"2000","unstructured":"Geubel AP, Sempoux CL. Drug and toxin-induced bile duct disorders. J Gastroenterol Hepatol. 2000;15:1232\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"2132_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0041-1729972","volume":"41","author":"F Bessone","year":"2021","unstructured":"Bessone F, Hernandez N, Tanno M, Roma MG. Drug-induced vanishing bile duct syndrome: from pathogenesis to diagnosis and therapeutics. Semin Liver Dis. 2021;41:331\u201348.","journal-title":"Semin Liver Dis"},{"key":"2132_CR7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011;53:1377\u201387.","journal-title":"Hepatology"},{"key":"2132_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep.1840200610","volume":"20","author":"D Moradpour","year":"1994","unstructured":"Moradpour D, Altorfer J, Flury R, et al. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology. 1994;20:1437\u201341.","journal-title":"Hepatology"},{"key":"2132_CR9","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012"},{"key":"2132_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.28967","volume":"65","author":"HL Bonkovsky","year":"2017","unstructured":"Bonkovsky HL, Kleiner DE, Gu J, et al. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology. 2017;65:1267\u201377.","journal-title":"Hepatology"},{"key":"2132_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1097\/00042737-200211000-00019","volume":"14","author":"C Schwarze","year":"2002","unstructured":"Schwarze C, Schmitz V, Fischer HP, Sauerbruch T, Spengler U. Vanishing bile duct syndrome associated with elevated pancreatic enzymes after short-term administration of amoxicillin. Eur J Gastroenterol Hepatol. 2002;14:1275\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2132_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3350\/kjhep.2011.17.3.229","volume":"17","author":"JS Kim","year":"2011","unstructured":"Kim JS, Jang YR, Lee JW, et al. A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage. Korean J Hepatol. 2011;17:229\u201332.","journal-title":"Korean J Hepatol"},{"key":"2132_CR13","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1177\/0300060519868594","volume":"47","author":"L Li","year":"2019","unstructured":"Li L, Zheng S, Chen Y. Stevens\u2013Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child. J Int Med Res. 2019;47:4537\u201343.","journal-title":"J Int Med Res"},{"key":"2132_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/01.mpg.0000178086.44155.73","volume":"41","author":"LA Smith","year":"2005","unstructured":"Smith LA, Ignacio JR, Winesett MP, et al. Vanishing bile duct syndrome: amoxicillin\u2013clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 2005;41:469\u201373.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2132_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4253\/wjge.v4.i8.376","volume":"4","author":"H Li","year":"2012","unstructured":"Li H, Li X, Liao XX, et al. Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis. World J Gastrointest Endosc. 2012;4:376\u20138.","journal-title":"World J Gastrointest Endosc"},{"key":"2132_CR16","doi-asserted-by":"publisher","first-page":"e233052","DOI":"10.1136\/bcr-2019-233052","volume":"13","author":"A Hashim","year":"2020","unstructured":"Hashim A, Barnabas A, Miquel R, Agarwal K. Successful liver transplantation for drug-induced vanishing bile duct syndrome. BMJ Case Rep. 2020;13:e233052.","journal-title":"BMJ Case Rep"},{"key":"2132_CR17","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1111\/bcp.15445","volume":"88","author":"K Faragalla","year":"2022","unstructured":"Faragalla K, Lau H, Wang HL, Liu J. Cloxacillin-induced acute vanishing bile duct syndrome: a case study and literature review. Br J Clin Pharmacol. 2022;88:4633\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"2132_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1440-1754.2008.01291.x","volume":"44","author":"H Tajiri","year":"2008","unstructured":"Tajiri H, Etani Y, Mushiake S, Ozono K, Nakayama M. A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder. J Paediatr Child Health. 2008;44:234\u20136.","journal-title":"J Paediatr Child Health"},{"key":"2132_CR19","doi-asserted-by":"publisher","first-page":"e8009","DOI":"10.1097\/MD.0000000000008009","volume":"96","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Bao L, Yu X, et al. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: a case report. Medicine (Baltimore). 2017;96:e8009.","journal-title":"Medicine (Baltimore)"},{"key":"2132_CR20","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1111\/jdv.14290","volume":"31","author":"S Momen","year":"2017","unstructured":"Momen S, Dangiosse C, Wedgeworth E, Walsh S, Creamer D. A case of toxic epidermal necrolysis and vanishing bile duct syndrome, requiring liver transplantation. J Eur Acad Dermatol Venereol. 2017;31:e450\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2132_CR21","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.3748\/wjg.14.4697","volume":"14","author":"G Okan","year":"2008","unstructured":"Okan G, Yaylaci S, Peker O, Kaymakoglu S, Saruc M. Vanishing bile duct and Stevens\u2013Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol. 2008;14:4697\u2013700.","journal-title":"World J Gastroenterol"},{"key":"2132_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MCG.0b013e3181a51af9","volume":"44","author":"W Robinson","year":"2010","unstructured":"Robinson W, Habr F, Manlolo J, Bhattacharya B. Moxifloxacin associated vanishing bile duct syndrome. J Clin Gastroenterol. 2010;44:72\u20133.","journal-title":"J Clin Gastroenterol"},{"key":"2132_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0168-8278(02)00268-4","volume":"37","author":"L Bataille","year":"2002","unstructured":"Bataille L, Rahier J, Geubel A. Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn\u2019s disease. J Hepatol. 2002;37:696\u20139.","journal-title":"J Hepatol"},{"key":"2132_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0034-1375964","volume":"34","author":"C Levine","year":"2014","unstructured":"Levine C, Trivedi A, Thung SN, Perumalswami PV. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review. Semin Liver Dis. 2014;34:246\u201351.","journal-title":"Semin Liver Dis"},{"key":"2132_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S1665-2681(19)32029-0","volume":"5","author":"W Karnsakul","year":"2006","unstructured":"Karnsakul W, Arkachaisri T, Atisook K, Wisuthsarewong W, Sattawatthamrong Y, Aanpreung P. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms. Ann Hepatol. 2006;5:116\u20139.","journal-title":"Ann Hepatol"},{"key":"2132_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1742-7843.2009.00474.x","volume":"106","author":"D Juricic","year":"2010","unstructured":"Juricic D, Hrstic I, Radic D, et al. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man. Basic Clin Pharmacol Toxicol. 2010;106:62\u20135.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2132_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0072-9752(10)97027-9","volume":"97","author":"SD Silberstein","year":"2010","unstructured":"Silberstein SD. Migraine preventive treatment. Handb Clin Neurol. 2010;97:337\u201354.","journal-title":"Handb Clin Neurol"},{"key":"2132_CR28","doi-asserted-by":"publisher","first-page":"1220737394","DOI":"10.1177\/0300060520937842","volume":"48","author":"A Zubarev","year":"2020","unstructured":"Zubarev A, Haji K, Li M, Tiruvoipati R, Botha J. Meropenem-induced vanishing bile duct syndrome: a case report. J Int Med Res. 2020;48:1220737394.","journal-title":"J Int Med Res"},{"key":"2132_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5223\/pghn.2013.16.4.273","volume":"16","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Jwa HJ, Kim KS, Gang DY, Kim JY. Urosodeoxycholic acid therapy in a child with trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Pediatr Gastroenterol Hepatol Nutr. 2013;16:273\u20138.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"2132_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12328-019-01022-5","volume":"13","author":"PR Kathi","year":"2020","unstructured":"Kathi PR, Tama M, Ehrinpreis M, et al. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim\/sulfamethoxazole and dapsone. Clin J Gastroenterol. 2020;13:276\u201380.","journal-title":"Clin J Gastroenterol"},{"issue":"5","key":"2132_CR31","first-page":"430","volume":"58","author":"MQ Lu","year":"2020","unstructured":"Lu MQ, Gong JY, Li CY, et al. A case of drug-associated vanishing bile duct syndrome. Chin J Pediatr. 2020;58(5):430\u20131 (in Chinese).","journal-title":"Chin J Pediatr"},{"issue":"5","key":"2132_CR32","first-page":"1051","volume":"23","author":"J Li","year":"2019","unstructured":"Li J, Zhao LL, Ye LH, et al. Two cases of drug\u2043induced vanishing bile duct syndrome. Anhui Med Pharm J. 2019;23(5):1051\u20133 (in Chinese).","journal-title":"Anhui Med Pharm J"},{"key":"2132_CR33","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340\u201352.","journal-title":"Gastroenterology"},{"key":"2132_CR34","doi-asserted-by":"publisher","first-page":"102015","DOI":"10.1016\/j.clinre.2022.102015","volume":"46","author":"P Wasuwanich","year":"2022","unstructured":"Wasuwanich P, Choudry H, So JM, Lowry S, Karnsakul W. Vanishing bile duct syndrome after drug-induced liver injury. Clin Res Hepatol Gastroenterol. 2022;46:102015.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2132_CR35","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1021\/tx0002435","volume":"14","author":"F Lakehal","year":"2001","unstructured":"Lakehal F, Dansette PM, Becquemont L, et al. Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes. Chem Res Toxicol. 2001;14:694\u2013701.","journal-title":"Chem Res Toxicol"},{"key":"2132_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tox.2005.07.015","volume":"216","author":"MA Carey","year":"2005","unstructured":"Carey MA, van Pelt FN. Immunochemical detection of flucloxacillin adduct formation in livers of treated rats. Toxicology. 2005;216:41\u20138.","journal-title":"Toxicology"},{"key":"2132_CR37","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1021\/acs.chemrestox.6b00253","volume":"29","author":"X Meng","year":"2016","unstructured":"Meng X, Earnshaw CJ, Tailor A, et al. Amoxicillin and clavulanate form chemically and immunologically distinct multiple haptenic structures in patients. Chem Res Toxicol. 2016;29:1762\u201372.","journal-title":"Chem Res Toxicol"},{"key":"2132_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1124\/mol.62.3.628","volume":"62","author":"DJ Naisbitt","year":"2002","unstructured":"Naisbitt DJ, Farrell J, Gordon SF, et al. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol Pharmacol. 2002;62:628\u201337.","journal-title":"Mol Pharmacol"},{"key":"2132_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","volume":"6","author":"ZX Liu","year":"2002","unstructured":"Liu ZX, Kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis. 2002;6:755\u201374.","journal-title":"Clin Liver Dis"},{"key":"2132_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1089-3261(03)00032-1","volume":"7","author":"C Levy","year":"2003","unstructured":"Levy C, Lindor KD. Drug-induced cholestasis. Clin Liver Dis. 2003;7:311\u201330.","journal-title":"Clin Liver Dis"},{"key":"2132_CR41","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","volume":"117","author":"ML Hautekeete","year":"1999","unstructured":"Hautekeete ML, Horsmans Y, Van Waeyenberge C, et al. HLA association of amoxicillin\u2013clavulanate\u2014induced hepatitis. Gastroenterology. 1999;117:1181\u20136.","journal-title":"Gastroenterology"},{"key":"2132_CR42","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","volume":"50","author":"JD Amaral","year":"2009","unstructured":"Amaral JD, Viana RJ, Ramalho RM, Steer CJ, Rodrigues CM. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J Lipid Res. 2009;50:1721\u201334.","journal-title":"J Lipid Res"},{"key":"2132_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"G Paumgartner","year":"2002","unstructured":"Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36:525\u201331.","journal-title":"Hepatology"},{"key":"2132_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","volume":"35","author":"KN Lazaridis","year":"2001","unstructured":"Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol. 2001;35:134\u201346.","journal-title":"J Hepatol"},{"key":"2132_CR45","doi-asserted-by":"publisher","first-page":"e1194","DOI":"10.1542\/peds.2013-2239","volume":"134","author":"JC White","year":"2014","unstructured":"White JC, Appleman S. Infliximab\/plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis. Pediatrics. 2014;134:e1194\u20138.","journal-title":"Pediatrics"},{"key":"2132_CR46","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/MPG.0b013e3182a95951","volume":"57","author":"Y Kawasaki","year":"2013","unstructured":"Kawasaki Y, Matsubara K, Hashimoto K, et al. Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis. J Pediatr Gastroenterol Nutr. 2013;57:e30\u20131.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-023-02132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-023-02132-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-023-02132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T18:34:27Z","timestamp":1717180467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-023-02132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1007\/s15010-023-02132-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest\/competing interest to disclose with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}